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Key summary points
Aim Investigate if 4AT score predicts 1 year mortality and explore the sensitivity and specificity of the 4AT when applied as part 
of a clinical routine.
Findings 4AT score is one of several clinical characteristics predicting 1 year mortality. The 4AT has reasonable sensitivity and 
specificity to detect delirium in a clinical routine setting.
Message The 4AT seems to be a useful tool for delirium screening and may predict mortality.
Abstract
Purpose Delirium is common and associated with poor outcomes, partly due to underdetection. We investigated if the delirium 
screening tool 4 A’s test (4AT) score predicts 1 year mortality and explored the sensitivity and specificity of the 4AT when applied 
as part of a clinical routine.
Methods Secondary analyses of a prospective study of 228 patients acutely admitted to a Medical Geriatric Ward. Physicians without 
formal training conducted the index test (the 4AT); a predefined cut-off ≥ 4 suggested delirium. Reference standard was delirium 
diagnosed by two geriatricians using the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5). We calculated hazard 
ratios (HR) using Cox regression based on the groups 4AT = 0, 1–3, 4–7 and ≥ 8, first unadjusted, then adjusted for the covariates 
age, comorbidity, and personal activities of daily living. We calculated sensitivity, specificity, and the area under the receiver operat-
ing curve (AUC).
Results Mean age of patients was 86.6 years, 139 (61.0%) were female, 78 (34.2%) had DSM-5 delirium; of these, 56 had 4AT-
delirium. 1 year mortality was 27.6% (63 patients). Compared to 4AT score 0, the group 4AT ≥ 8 had increased 1 year mortality (HR 
2.86, 95% confidence interval 1.28–6.37, p = 0.010). The effect was reduced in multiadjusted analyses (HR 1.69, 95% confidence 
interval 0.70–4.07, p = 0.24). Sensitivity, specificity, and AUC were 0.72, 0.84, and 0.88, respectively.
Conclusions 4AT ≥ 8 indicates increased mortality, but the effect was reduced in multiadjusted analyses. 4AT had acceptable 
sensitivity and specificity when applied as a clinical routine.
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Background
Delirium is an acute disturbance in attention, awareness and 
cognition occurring secondary to acute illness, trauma or 
surgery [1]. Delirium is common in all hospital settings, 
affects about 30% of hospitalized older patients and is asso-
ciated with elevated risk of death, dementia, and institution-
alization [2–4]. The costs of delirium are substantial [5]. 
Older age, cognitive impairment, comorbidity and frailty 
are the most significant risk factors [6, 7].
Although common, delirium is underdiagnosed in as 
many as 60% of cases [8], and underdetection may contrib-
ute to poor outcomes [9]. Screening for delirium is, there-
fore, recommended in hospitalized older patients [2, 4]. The 
4 A’s test (4AT) is a short screening tool for delirium and 
cognitive impairment developed in the UK [10]. It has been 
translated into several languages, and validation studies 
report high sensitivity and specificity for the diagnosis of 
delirium [11–18]. A recent meta-analysis including 3702 
patients concluded that the 4AT has a sensitivity and speci-
ficity of 88% for delirium screening [19].
The authors of the 4AT claim that health care profes-
sionals using the 4AT need no formal training [10]. One 
study investigated sensitivity and specificity of the 4AT 
when performed by nurses [20], but to our knowledge, no 
studies have investigated sensitivity and specificity of the 
4AT when performed by physicians outside strict validation 
studies. Two recent papers indicate that 4AT score predict 
in-hospital mortality [21, 22], but it is unknown whether 
4AT score may predict long-term mortality. The aim of this 
paper is (1) to investigate whether total 4AT score predicts 
1 year mortality in hospitalized geriatric patients and (2) to 
explore the sensitivity and specificity of the 4AT for diag-
nosing delirium when applied as part of a clinical routine 
by physicians without formal training in scoring the 4AT.
Methods
This paper reports secondary analyses of data collected in 
a project on delirium motor subtypes (DeMo) [23–25] and 
follows the reporting practice recommended in the Stand-
ards for Reporting of Diagnostic Accuracy Studies (STARD) 
[26]. The Regional Committee for Medical and Health 
Research Ethics of Mid-Norway approved the study (REK 
Central 2015/474) which was conducted according to the 
standards in the Declaration of Helsinki.
Settings and participants
Consecutive patients ≥ 75 years who were acutely admit-
ted to the medical geriatric ward at St. Olavs Hospital, 
Trondheim University Hospital, Norway, between May 
2015 and January 2017 were eligible for inclusion. The only 
exclusion criteria were inability to speak/read Norwegian 
and previous participation in the study, and no patients were 
excluded from the DeMo-study or this sub-study due to sen-
sory impairments, functional status, severity of acute disease 
or cognitive impairment as is often the case in studies on 
geriatric patients. Patients could consent to participation if 
considered to have the capacity to do so; for those without 
the capacity, a proxy could sign the consent form.
St Olavs Hospital is a university hospital with 1000 beds, 
serving as a tertiary hospital for the 455,000 inhabitants of 
the region Trøndelag and as local hospital for the 200,000 
inhabitants in the city of Trondheim and four nearby munici-
palities. The acute geriatric ward has 15 single-bed rooms 
and is an integrated part of the medical department, mean 
length of stay during the study period was 7.6 days. Most 
patients arrive as acute admissions from the emergency 
department, a substantial number arrive as transfers from 
other departments. Patients receive comprehensive geriatric 
care [27] from a team of physicians, nurses, physiothera-
pists, and occupational therapists, all integrated at the ward 
[23–25].
Index test—the 4AT
Parallel to the DeMo project, we sought to implement the 
4AT in the daily routine at the ward to increase the focus on 
delirium among the staff and improve the diagnostic work-
up for delirium. Physicians at the ward, four specialists in 
geriatric medicine and four residents in training for geriatric 
medicine, completed the Norwegian version of the 4AT [28] 
the first day after the patient’s arrival. The physicians were 
encouraged to assess all new patients admitted to the ward 
including those participating in the DeMo project consecu-
tively but were not reminded about the 4AT if they did not 
complete the test after the first day. Figure 1 illustrates the 
inclusion process. The physicians were given brief informa-
tion about the DeMo project and the 4AT but did not receive 
formal training in scoring the 4AT. All clinical information 
was available to the physicians completing the index test.
The 4AT contains four items: (1) a bedside evaluation of 
alertness; (2) the Abbreviated Mental Test 4 (AMT4); (3) 
the months of the year backwards (MOTYB) attention task, 
and (4) an evaluation of recent acute changes or fluctua-
tions in mental status. Item 1 is scored 0 for normal alert-
ness and 4 for altered alertness. Items 2 and 3 are scored 
0 to 2. Item 4 is scored 0 if acute changes or fluctuations 
in mental status are not present, and 4 if such changes are 
present. The maximum total score is 12 [18]. We used the 
same predefined cut-off scores as other validation studies; 
a score of 0 indicates no cognitive problems, a score of 1–3 
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indicates cognitive impairment and a score ≥ 4 indicates 
ongoing delirium [11–18].
Reference standard
The reference standard diagnosis was delirium according 
to the Diagnostic and Statistical Manual of Mental Disor-
ders 5 (DSM-5) criteria [1]. The assessment was completed 
by the first author and a now retired professor in geriatric 
medicine. The first author visited new patients and assessed 
awareness and alertness based on items from the Memorial 
Delirium Assessment Scale (MDAS) [29], tested attention 
by use of the digit span and tested cognitive function by use 
of the orientation and memory items from the MDAS. As a 
supplement, the first author did chart review and interviewed 
nurses, doctors, and proxies about signs of delirium. Then, 
the two assessors discussed all cases, considering all avail-
able information from the entire hospital stay when deciding 
if the patient filled the DSM-5 criteria for delirium or not.
The 4AT score was not used in the reference standard 
assessment, but the assessors were not strictly blinded to the 
result of the index test. The result of the reference standard 
assessment was not available to the ward’s physicians.
Data collection
Descriptive data were collected prospectively and were 
based on all available information from hospital records 
and interviews with patients and proxies. We used the 
Global Deterioration Scale (GDS) as a measure of pre-
hospital cognitive function [30]. The GDS ranges from 
1 to 7, 1 indicating no cognitive problems and 7 repre-
senting end-stage dementia. We defined dementia as a 
score of ≥ 4, since a score of 3 describes mild cognitive 
impairment and a score of 4 describes mild dementia [30]. 
We used the Barthel Index (BI) based on interviews with 
proxies as a measure of pre-hospital function in personal 
activities of daily living (pADL) [31]. BI ranges from 0 to 
Included in original study
N = 311
Physicians at the ward 
completed the 4AT 
during hospital stay
Included in present study
n = 228
Physicians at the ward 
did not complete the 
4AT during hospital stay










Fig. 1  Flowchart illustrating patients included in the original study and the present study
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20; an increasing score indicates independency in pADL. 
We used the Cumulative Illness Rating Scale (CIRS) as 
a measure of comorbidity. CIRS ranges from 0 to 56; an 
increasing score illustrates increasing comorbidity and is 
associated with elevated mortality [32]. We used a modi-
fied APACHE II score as a measure of severity of acute 
illness [33]. APACHE II ranges from 0 to 71; an increas-
ing score indicates elevated level of organ failure. Data on 
1 year mortality were collected from the hospital records, 
which are synchronized with the National Death Registry.
Statistical analyses
We report continuous data as means and standard devia-
tions (SD) and dichotomous data as numbers and per-
centages. To evaluate the association between 4AT score 
and 1 year mortality rate we constructed Kaplan–Meier 
plots based on groups consisting of a 4AT score of 0, 
1–3, 4–7 and ≥ 8. We calculated hazard ratios (HR) using 
Cox proportional hazards regression analyses based on 
the same groups. The choice of these groups were based 
on an assumption that patients with no signs of cogni-
tive impairment (4AT = 0) would have the best prog-
nosis, followed by patients with cognitive impairment 
without delirium (4AT 1–3) and patients with delirium 
(4AT ≥ 4). Further, we wanted to explore if very high 
scores (4AT ≥ 8) indicated particularly poor prognosis, 
as we presumed that a very high 4AT-score would indi-
cate a more certain delirium. HR was calculated unad-
justed, then adjusted one at a time and simultaneously for 
age, CIRS, and BI, since these variables have prognostic 
impact in older adults [34, 35]. The ability of the 4AT to 
discriminate between patients with and without delirium 
was examined using the area (AUC) under the receiver 
operating characteristic curve (ROC). We calculated sen-
sitivity and specificity for the 4AT as a screening test for 
delirium with a cut-off of ≥ 4, including Wilson Score 
confidence intervals. We report 95% confidence intervals 
(CI) where relevant, and regard two-sided p-values under 
0.05 to indicate statistical significance. Analyses were 
carried out in SPSS 25, StatXact 11, and Stata 15.
Results
In total, 311 patients were included in the DeMo project. 
Physicians at the ward completed the 4AT in 228 patients 
(73.3%), who constitute the sample reported here. Of 
these, 139 (61.0%) were women, 117 (51.3%) had demen-
tia, and 218 (95.6%) were home-living. Mean length of 
stay for patients with delirium was 10.3 (SD 6.9) days. 
Seventy-eight patients (34.2%) had delirium according to 
the DSM-5 criteria, 80 (35.1%) had delirium according to 
the 4AT, and 63 (27.6%) died during the 1 year follow-up. 
Table 1 shows the number of patients, baseline character-
istics, DSM-5 delirium, and 1 year mortality rates in the 
different groups of 4AT scores.
Figure 2 illustrates the Kaplan–Meier survival curves 
based on the four categories of 4AT score. The figure indi-
cates that the 4AT categories 1–3 and 4–7 have somewhat 
lower survival than category 0, and that those with a 4AT 
score of ≥ 8 seem to have substantially lower survival. Com-
pared to 4AT = 0, HR for the group 4AT = 1–3 was 1.52 
(95% CI 0.80–2.87, p = 0.20), HR for the group 4AT = 4–7 
was 1.30 (95% CI 0.66–2.54, p = 0.45) and HR for the group 
4AT ≥ 8 was 2.86 (95% CI 1.28–6.37, p = 0.010). Adjust-
ing for covariates did not change the effect for the groups 
4AT = 1–3 and 4–7 substantially but reduced the effect in the 
group 4 AT ≥ 8, (HR = 1.69, 95% CI 0.70–4.07, p = 0.24).
Figure 3 shows the ROC curve. The estimated area AUC 
under the ROC curve was 0.88 (CI 0.83–0.92). Among the 
78 patients with DSM-5 delirium, 56 (71.8%) had a 4AT 
score of ≥ 4 and 22 (28.2%) had a 4AT score of ≤ 3, giv-
ing a sensitivity of 0.72 (CI 0.61–0.81). Among the 150 
patients without DSM-5 delirium, 126 (84%) had a 4AT 
score of ≤ 3, giving a specificity of 0.84 (CI 0.77–0.89).
In total, 14 (6.1%) patients were given a score of 4 on 
item 1 and 76 (33.3%) were given a score of 4 on item 
4. All patients with a score of 4 on item 1 had DSM-5 
delirium, whereas 54 (71.1%) of the 76 patients with a 
score of 4 on item 4 had DSM-5 delirium. Among patients 
with DSM-5 delirium, 24 out of 78 (30.8%) were given a 
score of 0 on item 4.
Discussion
In this study on acutely admitted geriatric patients, a 4AT 
score of ≥ 8 predicted 1 year mortality in unadjusted analy-
ses, but this effect was reduced in multivariate analyses. 
The 4AT had reasonable sensitivity and good specificity 
for detecting delirium, even when performed by physicians 
without formal training working in a routine clinical set-
ting outside a strict validation study.
These results indicate that a 4AT score of ≥ 8 predicts 
poor outcomes; the 1 year mortality in this group was close 
to 50%. In this study, 89.5% of the patients with a 4AT 
score of ≥ 8 had DSM-5 delirium, and in view of previous 
studies [3], we believe our results simply indicate that geri-
atric patients with manifest delirium have increased risk 
of mortality. A challenge is to identify the patients with 
delirium who have particularly poor outcomes, and a sys-
tematic review indicate that older patients with long-lasting 
delirium, hypoactive subtype, high delirium severity and 
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comorbid dementia, and depression have poorer outcomes 
[35]. Recent studies have documented that a high 4AT score 
indicates poor outcomes included elevated short-time mor-
tality [21, 22]. Our results indicate that the 4AT may predict 
long-term mortality as well, but that other factors like age, 
comorbidity and particularly functional status also provide 
important information about prognosis in geriatric patients 
[34].
Table 1  Baseline 
characteristics, DSM-5 delirium, 
and 1 year mortality for the 
entire study population and the 
subgroups of 4AT scores of 0, 
1–3, 4–7, and 8–12
*p < 0.05
a p values were calculated using Cox regression models for 1 year mortality, a Cochran Armitage test for 
trend, and linear regression for continuous variables
b GDS Global Deterioration Scale
c Barthel Index before admission
d CIRS Cumulative Illness Rating Scale, total score
e APACHE-II Acute Physiology and Chronic Health Evaluation
f Dementia defined as GDS score ≥ 4
g DSM Diagnostic and Statistical Manual of Mental Disorders
4AT score All p  valuea
0 1–3 4–7 8–12
Number (%) 83 (36.4) 65 (28.5) 61 (26.7) 19 (8.3) 228 (100)
Age
Mean (SD)
85.7 (5.2) 87.2 (5.1) 87.2 (5.2) 86.1 (5.1) 86.6 (5.2) 0.23
GDSb (1–7)
Mean (SD)
2.3 (1.4) 3.7 (1.6) 4.2 (1.4) 4.4 (1.1) 3.4 (1.7)  < 0.001*
Barthel  Indexc (0–20)
Mean (SD)
17.5 (2.9) 15.9 (3.5) 15.7 (3.9) 13.8 (5.1) 16.3 (3.7)  < 0.001*
CIRSd (0–56)
Mean (SD)
12.4 (4.3) 14.0 (4.4) 12.8 (4.2) 15.8 (5.1) 13.2 (4.4) 0.03*
APACHE-IIe (0–71)
Mean (SD)
9.3 (3.1) 9.3 (2.8) 9.2 (2.3) 9.2 (2.8) 9.3 (2.8) 0.83
Dementiaf (%) 16 (19.3) 42 (64.6) 44 (72.1) 15 (78.9) 117 (51.3)  < 0.001*
DSMg-5 delirium (%) 2 (2.4) 20 (30.8) 39 (63.9) 17 (89.5) 78 (34.2)  < 0.001*
1 year mortality (%) 18 (21.7) 20 (30.8) 16 (26.2) 9 (47.4) 63 (27.6) 0.011*
Fig. 2  Kaplan–Meier survival curves for the four categories of 4AT 
score
Fig. 3  Receiver operating characteristic curve (ROC) for the 4AT as 
predictor of DSM-5 delirium
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Validation studies have demonstrated high sensitivity and 
specificity of the 4AT as a delirium screening tool [19], but 
to our knowledge, this paper is the first reporting sensitivity 
and specificity of the 4AT when conducted by physicians 
outside strict validation studies; the reasonable sensitivity 
and specificity we report support the use of 4AT as a delir-
ium screening tool. Still, our material raises concerns about 
items 1 and 4. Item 1 addresses alertness, a core feature of 
delirium. In our sample, only 14 patients (6.1%) received 
a score of 4 on item 1. This is remarkably few, since 78 
patients (34.2%) had delirium according to the DSM-5 cri-
teria, and results may indicate that physicians, even geriatri-
cians and residents training for geriatric medicine, do not 
fully understand the concept of alertness. Since the index 
test and the reference standard were not performed strictly 
within a limited time interval, an alternative explanation is 
that an altered level of alertness was not present when the 
index test was performed and was obvious when reference 
assessment was completed. Further, the physicians missed 
acute changes and/or fluctuations in mental status in 24 out 
of the 78 patients (30.8%) with DSM-5 delirium, which 
may indicate that item 4 is more frequently underscored 
in real-life settings than in validation studies. Reasons for 
underscoring may be that 4AT assessors, who were busy 
clinicians, did not have proxies available or did not find the 
time to talk to proxies and nurses when completing item 
4 and consequently missed important information about 
acute onset and fluctuation. Another possibility may be that 
the assessors did not notice and emphasize the information 
about fluctuations. A recent review and meta-analysis of 
diagnostic accuracy of the 4AT requests studies identify-
ing training needs, and we believe our findings indicate that 
health care staff should have formal training before using the 
4AT, with a focus on how to score items 1 and 4 [19, 20].
More than half of the patients described in this paper 
had dementia according to our definition (GDS ≥ 4). Since 
the DeMo project was designed with a pragmatic diagnostic 
approach to dementia, our data should not be used to validate 
the 4AT in patients with dementia. Still, Table 1 indicates 
some interesting trends. First, 19.3% of those scoring 0 on 
the 4AT have dementia according to our definition. Further, 
dementia is more common in those with a 4AT score indicat-
ing delirium than those with a 4AT score indicating cogni-
tive impairment but not ongoing delirium. This is in line 
with previous studies finding that dementia is a strong risk 
factor for delirium [6] and may indicate that patients with 
delirium with no known dementia diagnosis should be exam-
ined for dementia later. Table 1 may also indicate increas-
ing levels of comorbidity and lower pADL-function with 
an increasing 4AT score, raising the question as to whether 
the 4AT could be used to identify vulnerable patients in a 
broader sense than just cognitive impairment, for instance 
patients with functional impairment and risk of falls.
The major limitations of the study are the design with 
secondary analyses and that the index test and the refer-
ence standard were not strictly conducted within a limited 
period, introducing the possibility that the patients could 
be free of delirium symptoms when the index test was con-
ducted but have more pronounced symptoms later. These 
limitations could be an explanation to the concerns dis-
cussed about item 1 and 4 of the 4AT, but we still believe 
that these concerns are valid since both tests were done 
within a relatively short timeframe of the same hospitali-
zation. Further, sensitivity could be higher than 0.72 if the 
reference assessment had been conducted immediately after 
the index test. Other limitations include the fact that the 
assessors of the reference standard were not strictly blinded 
to the results of the index test and that the first author on 
a general basis occasionally supervised junior doctors on 
how to score the 4AT, introducing a possible bias. Our 
approach to diagnose dementia was pragmatic, and the data 
on 4AT score and dementia must be interpreted carefully. 
Our sample consists of frail geriatric patients, so results 
may not be generalizable to fit hospitalized adults. The 
fact that the study was not conducted as a strict validation 
study could also be considered as a strength since we can 
report how the 4AT performs as a delirium screening tool 
in a real-life setting. The completeness of data and the long 
follow-up are other strengths of the study.
To conclude, this study on acutely admitted geriatric 
patients demonstrated that a high 4AT score may indicate 
elevated 1 year mortality, although age, comorbidity, and 
pADL-function also provide information about mortality 
risk. The 4AT seems to have reasonable sensitivity and spec-
ificity as a delirium screening tool when applied as part of a 
clinical routine outside validation studies. Still, our results 
may indicate that health care professionals should get formal 
training before using the 4AT and that such training may 
improve the sensitivity of the 4AT for delirium screening.
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